Name of organisation
1) Department/Research groupFundación Centro Español de Investigación Farmacoepidemiológica
2) Organisation/affiliationFundación CEIFE
Short Name in the inventoryCEIFE
Administrative Contact
Title Dr
Last name García Rodríguez
First name Luis Alberto
Address line 1Almirante 28
Address line 2
Address line 3
CityMadrid
Postcode28004
CountrySpain
Phone number (incl. country code)34915313404
Alternative phone number
Fax number (incl. country code)34915312871
Scientific Contact
Title Dr
Last name García Rodríguez
First name Luis Alberto
Address line 1Almirante 28
Address line 2
Address line 3
CityMadrid
Postcode28004
CountrySpain
Phone number (incl. country code)34915313404
Alternative phone number
Fax number (incl. country code)34915312871
Alternative Scientific Contact
Title Dr
Last name Ruigómez
First name Ana
Address line 1Almirante 28-2
Address line 2
Address line 3
CityMadrid
Postcode28004
Country
Phone number (incl. country code)+34915311485
Alternative phone number
Fax number (incl. country code)
2. Description
The Centro Español de Investigación Farmacoepidemiológica-CEIFE (Spanish Centre for Pharmacoepidemiologic Research) is a research unit created in 1994 in Madrid. Its mission is to provide high quality research on drug safety and effectiveness, by means of epidemiologic studies utilizing computerized databases. Four main sources of information are used: General Practice Research Database and The Health Improvement Network, both in the UK, BIFAP Database in Madrid and Saskatchewan Database in Canada. CEIFE collaborates with industry, regulatory authorities and other universities at a national and international level. Permanent staff includes four epidemiologists and one information systems analyst. Postgraduate students and other research collaborators spend varying periods of time on a project-specific basis.
3. Category
Charity or non-profit organisation
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
Yes
No
Clinical Pharmacologist
No
Yes
Pharmacist
Yes
No
IT specialist
Yes
No
Ethics expertise
No
Yes
Regulatory expertise
No
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Endocrine disorders
Eye disorders
Gastrointestinal tract
Gynaecology
Liver disease
Malignant disease
Paediatrics
Pregnancy
Renal impairment
Respiratory diseases
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No